anastrozole has been researched along with Cardiovascular Stroke in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " We aimed to compare AIs and tamoxifen with regard to cardiovascular events among older breast cancer patients outside of clinical trials." | 3.91 | Are aromatase inhibitors associated with higher myocardial infarction risk in breast cancer patients? A Medicare population-based study. ( Kamaraju, S; Laud, P; Nattinger, AB; Neuner, J; Shi, Y; Smith, E, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamaraju, S | 1 |
| Shi, Y | 1 |
| Smith, E | 1 |
| Nattinger, AB | 1 |
| Laud, P | 1 |
| Neuner, J | 1 |
1 other study available for anastrozole and Cardiovascular Stroke
| Article | Year |
|---|---|
Are aromatase inhibitors associated with higher myocardial infarction risk in breast cancer patients? A Medicare population-based study.
Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast | 2019 |